Icosagen is a reputable and research-driven Contract Research, Development, and Manufacturing Organization (CRDMO) that caters to the needs of the biopharmaceutical, biotechnology, and diagnostic industries. Comprised of four entities, including Icosagen AS and its subsidiaries, Icosagen Cell Factory OÜ, Icosagen Technologies Inc., and IcoPark OÜ, the company has been in operation since 1999. They offer a wide range of services, from antibody discovery and development to protein production and analytics.

Their expertise also extends to cell line development, cell-based assays, and food microbiology testing. Icosagen is highly regarded for their ability to adapt to market forces and trends, placing the needs of their customers at the forefront. Through their integrated and efficient development capabilities, clients benefit from cost and time savings, as well as accelerated development times.

With a dedicated team of over 140 professionals, Icosagen has established itself as a leading biotechnology group, providing innovative solutions and custom-tailored services to global customers